275 results on '"Smits, Kim M"'
Search Results
2. Association between adjuvant therapy and survival in colorectal cancer patients according to metabolic Warburg-subtypes
3. Neuronal Distribution in Colorectal Cancer: Associations With Clinicopathological Parameters and Survival
4. Energy balance-related factors and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status
5. Bovine Meat and Milk Factor-like Sequences Are Frequently Detected in Renal Cell Carcinoma Tissues
6. A Systematic Review on Prognostic DNA Methylation Markers for Renal Cell Carcinoma: Are We Moving Forward?
7. Technical considerations in PCR-based assay design for diagnostic DNA methylation cancer biomarkers
8. Evaluation of a seven gene mutational profile as a prognostic factor in a population-based study of clear cell renal cell carcinoma
9. Mapping of Human Polyomavirus in Renal Cell Carcinoma Tissues.
10. Diagnostic DNA Methylation Biomarkers for Renal Cell Carcinoma: A Systematic Review
11. Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC
12. Data from Spectrin Repeat Containing Nuclear Envelope 1 and Forkhead Box Protein E1 Are Promising Markers for the Detection of Colorectal Cancer in Blood
13. Supplementary Table 1 from Spectrin Repeat Containing Nuclear Envelope 1 and Forkhead Box Protein E1 Are Promising Markers for the Detection of Colorectal Cancer in Blood
14. Supplementary Figure 1 from Spectrin Repeat Containing Nuclear Envelope 1 and Forkhead Box Protein E1 Are Promising Markers for the Detection of Colorectal Cancer in Blood
15. Supplementary Table 2 from Spectrin Repeat Containing Nuclear Envelope 1 and Forkhead Box Protein E1 Are Promising Markers for the Detection of Colorectal Cancer in Blood
16. PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer
17. Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review
18. The trans-DATA study: aims and design of a translational breast cancer prognostic marker identification study
19. Analysis of DNA methylation in cancer: location revisited
20. Epigenetics in renal cell cancer: mechanisms and clinical applications
21. Data from Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer
22. Supplementary Figure S2 from A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients
23. Supplementary Table 3 from CHFR Promoter Methylation Indicates Poor Prognosis in Stage II Microsatellite Stable Colorectal Cancer
24. Supplementary Table 2 from CHFR Promoter Methylation Indicates Poor Prognosis in Stage II Microsatellite Stable Colorectal Cancer
25. Supplementary Table 1 from CHFR Promoter Methylation Indicates Poor Prognosis in Stage II Microsatellite Stable Colorectal Cancer
26. Supplementary Table 5 from CHFR Promoter Methylation Indicates Poor Prognosis in Stage II Microsatellite Stable Colorectal Cancer
27. Supplementary Data from Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer
28. CCR Translation for This Article from Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer
29. Supplementary Figure 1 from A Let-7 MicroRNA SNP in the KRAS 3′UTR Is Prognostic in Early-Stage Colorectal Cancer
30. Supplementary Figure Legends and Supplementary Tables from A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients
31. Supplementary Data from GATA4 and GATA5 are Potential Tumor Suppressors and Biomarkers in Colorectal Cancer
32. Data from GATA4 and GATA5 are Potential Tumor Suppressors and Biomarkers in Colorectal Cancer
33. Supplementary Figure Legend from A Let-7 MicroRNA SNP in the KRAS 3′UTR Is Prognostic in Early-Stage Colorectal Cancer
34. Data from A Let-7 MicroRNA SNP in the KRAS 3′UTR Is Prognostic in Early-Stage Colorectal Cancer
35. Supplementary Table 4 from CHFR Promoter Methylation Indicates Poor Prognosis in Stage II Microsatellite Stable Colorectal Cancer
36. Supplementary Figures 1-4 from Methylation of TFPI2 in Stool DNA: A Potential Novel Biomarker for the Detection of Colorectal Cancer
37. Data from Methylation of TFPI2 in Stool DNA: A Potential Novel Biomarker for the Detection of Colorectal Cancer
38. Supplementary Table 1 from Methylation of TFPI2 in Stool DNA: A Potential Novel Biomarker for the Detection of Colorectal Cancer
39. Energy balance‐related factors in childhood and adolescence and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status
40. Association between mutational subgroups, Warburg‐subtypes, and survival in patients with colorectal cancer
41. Epigenetics in radiotherapy: Where are we heading?
42. Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review
43. Lessons from a systematic literature search on diagnostic DNA methylation biomarkers for colorectal cancer: how to increase research value and decrease research waste
44. Decision support systems for personalized and participative radiation oncology☆
45. Association between mutational subgroups, Warburg‐subtypes, and survival in patients with colorectal cancer.
46. The CpG island methylator phenotype in colorectal cancer: Progress and problems
47. Energy Balance–Related Factors and Risk of Colorectal Cancer Expressing Different Levels of Proteins Involved in the Warburg Effect
48. Energy balance‐related factors in childhood and adolescence and risk of colorectal cancer expressing different levels of proteins involved in the Warburg‐effect
49. Loss of SerpinA5 protein expression is associated with advanced-stage serous ovarian tumors
50. Expression of proteins associated with the Warburg‐effect and survival in colorectal cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.